NASDAQ:TRDA

Entrada Therapeutics Stock Forecast

etoro logo Buy TRDA
*Your capital is at risk
$7.72
+0.130 (+1.71%)
At Close: Jul 02, 2026
AI Analysis AI Analysis of TRDA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TRDA to Watchlist?
Some Reasons Why To Add TRDA:
  • Lower volatility than the market (beta -0.26)
  • Highly efficient cash conversion (100% FCF/OCF ratio)
  • Bullish long-term trend in place
PDF

Entrada Therapeutics, Inc. stock price ended at $7.72 on Thursday, after gaining 1.71%
(Updated on Jul 02, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 25, 2026 Gain 7.97%

The Entrada Therapeutics, Inc. stock price gained 1.71% on the last trading day (Thursday, 2nd Jul 2026), rising from $7.59 to $7.72. During the last trading day the stock fluctuated 5.66% from a day low at $7.60 to a day high of $8.03. The price has risen in 6 of the last 10 days and is up by 13.36% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 86 thousand more shares were traded than the day before. In total, 359 thousand shares were bought and sold for approximately $2.77 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -47.84% during the next 3 months and, with a 90% probability hold a price between $0.570 and $5.27 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

TRDA Signals & Forecast

Mostly positive signals in the chart today. The Entrada Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $7.54 and $6.78. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 36.64%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Entrada Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $7.12 and $6.85. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Entrada Therapeutics, Inc. finds support just below today's level at $7.12. If this is broken, then the next support from accumulated volume will be at $6.85 and $6.84.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.430 between high and low, or 5.66%. For the last week, the stock has had daily average volatility of 6.28%.

Our recommended stop-loss: $7.45 (-3.56%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 30 days ago.)

Trading Expectations (TRDA) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Entrada Therapeutics, Inc. to open at $7.78, and during the day (based on 14 day Average True Range), to move between $7.45 and $7.99, which gives a possible trading interval of +/-$0.547 (+/-7.34%) up or down from last closing price. If Entrada Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.74 (0.26%) than the support at $7.12 (7.77%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Entrada Therapeutics, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.490 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $7.78 ( 0.777%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TRDA Performance

Trading levels for TRDA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 8.21 6.35%
R2 8.05 4.22%
R1 7.94 2.90%
Price 7.72
S1 7.62 -1.35%
S2 7.51 -2.67%
S3 7.35 -4.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 7.74 0.259%
Price 7.72
S1 7.12 -7.77%
S2 6.85 -11.27%
S3 6.84 -11.40%

FAQ

What is the symbol for Entrada Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Entrada Therapeutics, Inc. is TRDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Entrada Therapeutics, Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Entrada Therapeutics, Inc. Stock?
Entrada Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Entrada Therapeutics, Inc. Stock.

What's the current price of Entrada Therapeutics, Inc. Stock?
As of the end of day on the Jul 02, 2026, the price of an Entrada Therapeutics, Inc. (TRDA) share was $7.72.

What is the 52-week high and low for Entrada Therapeutics, Inc. Stock?
The 52-week high for Entrada Therapeutics, Inc. Stock is $16.45 and the 52-week low is $4.93.

What is the market capitalization of Entrada Therapeutics, Inc. Stock?
As of the Jul 02, 2026, the market capitalization of Entrada Therapeutics, Inc. is 299.695M.

When is the next earnings date for Entrada Therapeutics, Inc.?
The upcoming earnings date for Entrada Therapeutics, Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT ENTRADA THERAPEUTICS, INC.
Entrada Therapeutics
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also eng...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE